Picton Mahoney Asset Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Picton Mahoney Asset Management’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-210,000	Closed	-$15.8M	–	919
2022 Q2	$15.8M	Buy	+210,000	New	+$9.33M	0.6%	26

Picton Mahoney Asset Management's TPTX Position: Q3 2022 in Review

Picton Mahoney Asset Management sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 210,000 shares — an estimated $15.8M sold.

Picton Mahoney Asset Management first reported a position in TPTX in Q2 2022 and held it in 1 quarter. The position peaked at $15.8M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Picton Mahoney Asset Management reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Picton Mahoney Asset Management sold 210,000 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $15.8M.
Picton Mahoney Asset Management first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Picton Mahoney Asset Management's Turning Point Therapeutics, Inc. Common Stock position peaked at $15.8M in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Picton Mahoney Asset Management's 13F filing for Q3 2022, filed 9 Nov 2022.